The Ministry of Health announced that it has begun the process to acquire a new treatment for cancer immediately after certification.
Pembrolizumab, which is used for negative triple type breast cancer, was certified by the European Medicines Authority (EMA) on the 19th of October.
The Ministry for Health issued a statement saying that since 2017, around 17 new cancer medicines have been given free of charge in the Government formulary. Around 500 patients benefitted from this medicine per year.
#MaltaDaily